BRAF and sarcoma: However, to our knowledge, there are few clinical trials about the treatment of sarcoma patients with the BRAF V600E mutation treated with BRAF inhibitors, and most reports of sarcoma patients treated with BRAF inhibitors are case reports (Table 2).